CoraLite®488-conjugated Albumin Monoclonal antibody

Albumin Monoclonal Antibody for FC (Intra), IF

Host / Isotype

Mouse / IgG1


human, rat, pig and More (1)


IF, FC (Intra)


CoraLite®488 Fluorescent Dye



Cat no : CL488-66051


ALB, albumin, DKFZp779N1935, GIG42, HSA, PRO0883, PRO0903, PRO1341, PRO1708, PRO2044, PRO2619, PRO2675, Serum albumin, UNQ696/PRO1341

Tested Applications

Positive IF detected inHepG2 cells
Positive FC detected inHepG2 cells
For other applications, we recommend the unconjugated version of this antibody, 66051-1-Ig

Recommended dilution

Immunofluorescence (IF)IF : 1:200-1:800
Sample-dependent, check data in validation data gallery

Published Applications

IFSee 1 publications below

Product Information

The immunogen of CL488-66051 is Albumin Fusion Protein expressed in E. coli.

Tested Reactivity human, rat, pig
Cited Reactivitymouse
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen Albumin fusion protein Ag9885
Full Name albumin
Calculated molecular weight 609 aa, 69 kDa
Observed molecular weight 66 kDa
GenBank accession numberBC034023
Gene symbol ALB
Gene ID (NCBI) 213
Conjugate CoraLite®488 Fluorescent Dye
Excitation/Emission maxima wavelengths488 nm / 515 nm
Form Liquid
Purification Method Protein G purification
Storage Buffer PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
Storage ConditionsStore at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

Albumin is the most abundant protein in blood plasma. Alterations of level of serum albumin are linked to variety of diseases. Albumin is expressed exclusively by well-differentiated hepatocytes, thus anti-albumin has been used to mark hepatocytes. (21388516, 23832071)


Product Specific Protocols
IF protocol for CL488 Albumin antibody CL488-66051Download protocol
FC protocol for CL488 Albumin antibody CL488-66051Download protocol
Standard Protocols
Click here to view our Standard Protocols



Mol Cell

WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.

Authors - Sixian Qi